Lapatinib Impurity 13;320337-48-2
WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com
Product Number: L079013
English Name: Lapatinib Impurity 13
English Alias: (5-(4-((3-chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl)furan-2-yl)methanol
CAS Number: 320337-48-2
Molecular Formula: C26H19ClFN3O3
Molecular Weight: 475.90
Product Advantages: Lapatinib Impurity 13 has high purity and good stability. Its structure is confirmed by multiple precise analytical methods such as nuclear magnetic resonance and mass spectrometry, and it remains stable and uniform under different experimental environments and storage conditions. As a reference substance, it can provide accurate and reliable data for Lapatinib impurity detection, ensuring accurate and highly reproducible detection results, providing a solid guarantee for pharmaceutical quality research and quality control, and facilitating quality control in drug research and production processes.
Application Fields:
Quality Control: As an impurity reference standard, it is used to establish and validate the detection methods for impurities in Lapatinib bulk drugs and formulations, ensuring that the sensitivity and specificity of the detection methods meet pharmaceutical quality standards and guaranteeing the consistency of drug quality.
Process Optimization: During the production of Lapatinib, by monitoring the content of this impurity and tracing the process steps of its generation, it helps to optimize the synthesis process, reduce impurity formation, and improve product quality and production efficiency.
Stability Studies: In drug stability tests, it analyzes the change trends of this impurity under different storage conditions (such as temperature, humidity, light), providing key data support for determining the shelf life and suitable storage conditions of drugs.
Background Description: Lapatinib is an important targeted drug for the treatment of HER2-positive breast cancer. In the process of its research, development, production, and quality control, impurity research is a key link to ensure drug safety and effectiveness. The presence of impurities may affect the efficacy and safety of the drug. As a related impurity of Lapatinib, in-depth research on Lapatinib Impurity 13 helps to comprehensively evaluate the quality of Lapatinib drugs, improve the drug quality evaluation system, and ensure the safety and effectiveness of clinical medication.
Research Status: Currently, research on Lapatinib Impurity 13 mainly focuses on detection technology and impurity generation mechanisms. In terms of detection technology, advanced methods such as Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry (UPLC-MS/MS) and high-resolution mass spectrometry are used to achieve precise detection of trace impurities. In the study of impurity generation mechanisms, the formation causes and influencing factors are analyzed by simulating drug synthesis reactions and storage environments, providing a theoretical basis for optimizing the production process and controlling impurities from the source. In addition, research on the impact of this impurity on the efficacy and safety of Lapatinib is also gradually being carried out
NOTE！
We can also customize related analogues and modified peptides including HPLC, MS, 1H-NMR, MS, HPLC, IR, UV, COA, MSDS.
This product is intended for laboratory use only!
WhatsAPP: +86 17386083646
E-mail: anna@molcoo.com
NEW IN STOCK!
The Molcoo Laboratory added drug impurity reference standards, including Baricitinib, Piperazine, Benzylpenicillin, Tranilast and multiple N-Nitroso drug impurities! Now available for immediate delivery!
China
